Software stock Veeva Systems (VEEV) is in buying range amid strong profit and sales growth stretching beyond the company’s 2013 initial public offering.
The IBD Leaderboard stock cleared a 35.79 alternative buy point in heavy volume on July 7 and rose just out of its 5% buy zone before easing back into range. The decline has occurred in light volume, which is ideal.